1. Home
  2. OVID vs TRT Comparison

OVID vs TRT Comparison

Compare OVID & TRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OVID
  • TRT
  • Stock Information
  • Founded
  • OVID 2014
  • TRT 1958
  • Country
  • OVID United States
  • TRT United States
  • Employees
  • OVID N/A
  • TRT N/A
  • Industry
  • OVID Biotechnology: Pharmaceutical Preparations
  • TRT Industrial Machinery/Components
  • Sector
  • OVID Health Care
  • TRT Technology
  • Exchange
  • OVID Nasdaq
  • TRT Nasdaq
  • Market Cap
  • OVID 20.6M
  • TRT 22.7M
  • IPO Year
  • OVID 2017
  • TRT N/A
  • Fundamental
  • Price
  • OVID $1.23
  • TRT $5.37
  • Analyst Decision
  • OVID Strong Buy
  • TRT
  • Analyst Count
  • OVID 4
  • TRT 0
  • Target Price
  • OVID $3.13
  • TRT N/A
  • AVG Volume (30 Days)
  • OVID 2.0M
  • TRT 2.0K
  • Earning Date
  • OVID 08-13-2025
  • TRT 09-22-2025
  • Dividend Yield
  • OVID N/A
  • TRT N/A
  • EPS Growth
  • OVID N/A
  • TRT N/A
  • EPS
  • OVID N/A
  • TRT 0.00
  • Revenue
  • OVID $6,651,000.00
  • TRT $35,548,000.00
  • Revenue This Year
  • OVID $708.13
  • TRT N/A
  • Revenue Next Year
  • OVID N/A
  • TRT N/A
  • P/E Ratio
  • OVID N/A
  • TRT $1,218.93
  • Revenue Growth
  • OVID 1070.95
  • TRT N/A
  • 52 Week Low
  • OVID $0.24
  • TRT $4.62
  • 52 Week High
  • OVID $1.47
  • TRT $7.88
  • Technical
  • Relative Strength Index (RSI)
  • OVID 70.64
  • TRT 47.85
  • Support Level
  • OVID $1.16
  • TRT $5.21
  • Resistance Level
  • OVID $1.30
  • TRT $5.50
  • Average True Range (ATR)
  • OVID 0.11
  • TRT 0.12
  • MACD
  • OVID 0.01
  • TRT -0.01
  • Stochastic Oscillator
  • OVID 78.00
  • TRT 33.33

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

About TRT Trio-Tech International

Trio-Tech International is a provider of third-party semiconductor testing and burn-in services through its laboratories in Southeast Asia. The company operates in four segments namely Manufacturing, Testing services, Distribution, and Real Estate. Its Manufacturing segment manufactures both front-end and back-end semiconductor test equipment and related peripherals. The Testing Services segment renders services to the manufacturer and purchaser of semiconductors and other entities. Its Distribution segment is involved in the distribution of its products. The company's Real Estate segment consists of investment in real estate. Its geographical area of operations includes the United States, Singapore, Malaysia, Thailand, and China. It derives maximum revenue from Testing services Segment.

Share on Social Networks: